Up a level |
Karlsson, Richard, Chopra, Pradeep, Joshi, Apoorva, Yang, Zhang, Vakhrushev, Sergey Y, Clausen, Thomas Mandel, Painter, Chelsea D, Szekeres, Gergo P, Chen, Yen-Hsi, Sandoval, Daniel R et al (show 8 more authors)
(2021)
Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates.
SCIENCE ADVANCES, 7 (52).
eabl6026-.
Schuurs, Zachariah P, Hammond, Edward, Elli, Stefano, Rudd, Timothy R ORCID: 0000-0003-4434-0333, Mycroft-West, Courtney J, Lima, Marcelo A, Skidmore, Mark A, Karlsson, Richard, Chen, Yen-Hsi, Bagdonaite, Ieva et al (show 7 more authors)
(2021)
Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 19.
pp. 2806-2818.
Guimond, Scott E, Mycroft-West, Courtney J, Gandhi, Neha S, Tree, Julia A, Le, Thuy T, Spalluto, C Mirella, Humbert, Maria V, Buttigieg, Karen R, Coombes, Naomi, Elmore, Michael J et al (show 32 more authors)
(2022)
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction.
ACS Central Science, 8 (5).
pp. 527-545.
Tree, Julia A, Turnbull, Jeremy E ORCID: 0000-0002-1791-754X, Buttigieg, Karen R, Elmore, Michael J, Coombes, Naomi, Hogwood, John, Mycroft-West, Courtney J, Lima, Marcelo A, Skidmore, Mark A, Karlsson, Richard et al (show 10 more authors)
(2021)
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
BRITISH JOURNAL OF PHARMACOLOGY, 178 (3).
pp. 626-635.